Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insmed (INSM) Enterprise Value (2016 - 2026)

Insmed's Enterprise Value history spans 17 years, with the latest figure at -$1.2 billion for Q1 2026.

  • Quarterly Enterprise Value fell 2.01% to -$1.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.2 billion through Mar 2026, down 2.01% year-over-year, with the annual reading at -$1.4 billion for FY2025, 0.26% changed from the prior year.
  • Enterprise Value came in at -$1.2 billion for Q1 2026, up from -$1.4 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$513.3 million in Q3 2022 to a low of -$1.9 billion in Q2 2025.
  • The 5-year median for Enterprise Value is -$1.1 billion (2022), against an average of -$1.1 billion.
  • Year-over-year, Enterprise Value surged 40.35% in 2024 and then tumbled 101.34% in 2025.
  • Insmed's Enterprise Value stood at -$1.1 billion in 2022, then soared by 32.03% to -$780.4 million in 2023, then plummeted by 83.72% to -$1.4 billion in 2024, then increased by 0.26% to -$1.4 billion in 2025, then grew by 14.44% to -$1.2 billion in 2026.
  • Per Business Quant, the three most recent readings for INSM's Enterprise Value are -$1.2 billion (Q1 2026), -$1.4 billion (Q4 2025), and -$1.7 billion (Q3 2025).